A Phase 2b study TLC-3595
Latest Information Update: 09 Nov 2023
At a glance
- Drugs TLC 3595 (Primary)
- Indications Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 09 Nov 2023 New trial record
Latest Information Update: 09 Nov 2023